Cannassure Therapeutics Ltd operates within the Nonresidential building operators sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cannassure Therapeutics Ltd with three other
companies in this sector in Israel:
Lodzia-Rotex Investment Ltd.
sales of 24.92 million Israel Shekels [US$7.14 million]
Vitala Capital Ltd
(31.56 million Israel Shekels [US$9.04 million]
Liberty Properties Ltd.
(30.21 million Israel Shekels [US$8.65 million]
During the year ended December of 2011, sales at
Cannassure Therapeutics Ltd were 30.91 million Israel Shekels (US$8.85 million).
decrease of 1.7%
versus 2010, when the company's sales were 31.44 million Israel Shekels.